171 related articles for article (PubMed ID: 2862011)
1. Modulation of somatostatin binding to rat pituitary membranes by exogenously administered growth hormone.
Katakami H; Berelowitz M; Marbach M; Frohman LA
Endocrinology; 1985 Aug; 117(2):557-60. PubMed ID: 2862011
[TBL] [Abstract][Full Text] [Related]
2. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
Kimura N; Hayafuji C; Konagaya H; Takahashi K
Endocrinology; 1986 Sep; 119(3):1028-36. PubMed ID: 2874016
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptors on rat anterior pituitary membranes.
Enjalbert A; Tapia-Arancibia L; Rieutort M; Brazeau P; Kordon C; Epelbaum J
Endocrinology; 1982 May; 110(5):1634-40. PubMed ID: 6122557
[TBL] [Abstract][Full Text] [Related]
4. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pituitary membrane receptors for somatostatin in the rat.
Srikant CB; Patel YC
Endocrinology; 1982 Jun; 110(6):2138-44. PubMed ID: 6122562
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase.
Epelbaum J; Enjalbert A; Krantic S; Musset F; Bertrand P; Rasolonjanahary R; Shu C; Kordon C
Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors are biologically active before they are inserted into the plasma membrane.
Steiner C; Dahl R; Sherman N; Trowbridge M; Vatter A; Robbins R; Draznin B
Endocrinology; 1986 Feb; 118(2):766-72. PubMed ID: 2867891
[TBL] [Abstract][Full Text] [Related]
9. Covalent labeling of the somatostatin receptor in rat anterior pituitary membranes.
Bruno JF; Berelowitz M
Endocrinology; 1989 Feb; 124(2):831-7. PubMed ID: 2563243
[TBL] [Abstract][Full Text] [Related]
10. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
Cuttler L; Welsh JB; Szabo M
Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
[TBL] [Abstract][Full Text] [Related]
11. Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells.
Draznin B; Sherman N; Sussman K; Dahl R; Vatter A
Endocrinology; 1985 Sep; 117(3):960-6. PubMed ID: 2862022
[TBL] [Abstract][Full Text] [Related]
12. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
Soya H; Suzuki M
Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a biotinylated somatostatin analog as a receptor probe.
Schonbrunn A; Lee AB; Brown PJ
Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
[TBL] [Abstract][Full Text] [Related]
14. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
[TBL] [Abstract][Full Text] [Related]
15. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
[TBL] [Abstract][Full Text] [Related]
16. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
Presky DH; Schonbrunn A
Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
[TBL] [Abstract][Full Text] [Related]
17. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
Murphy WA; Taylor JE; Moreau JP; Coy DH
Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro.
Soya H; Suzuki M
Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284
[TBL] [Abstract][Full Text] [Related]
19. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
